Exhibitors Search
a.cure
Booth no.
E41
| Exhibition | PARTNERING |
|---|---|
| Country | Korea, South |
| Address | 204 Convensia-daero, Yeonsu-gu, Incheon, Republic of Korea |
| Tel (Rep.) | -000-0000 |
| Website | http://www.adotcure.com/ |
Company Introduction
a.cure leverages AI-based voice data analysis to detect and predict disease risks at an early stage.
The first pipeline is Heart to Voice (H2V) - an AI solution for heart failure detection and severity prediction.
◎ Heart to Voice (H2V)
· Up to 90.4% accuracy demonstrated in initial research and clinical studies
· Exploratory trials underway to achieve 95% accuracy and severity prediction
· Competitive edge: higher Performance, Accessibility, and Scalability
→ extendable from medical products to non-medical products and services
a.cure brings together leading experts across medical and AI domains, including Korea’s first DTx (Somzz), with execution capabilities from R&D to clinical validation and productization.
The company has established strong partnership networks and has the foundation in place for global expansion.
a.cure expands beyond heart failure to kidney failure, COPD, and other conditions, positioning as a leader in voice biomarkers.
The first pipeline is Heart to Voice (H2V) - an AI solution for heart failure detection and severity prediction.
◎ Heart to Voice (H2V)
· Up to 90.4% accuracy demonstrated in initial research and clinical studies
· Exploratory trials underway to achieve 95% accuracy and severity prediction
· Competitive edge: higher Performance, Accessibility, and Scalability
→ extendable from medical products to non-medical products and services
a.cure brings together leading experts across medical and AI domains, including Korea’s first DTx (Somzz), with execution capabilities from R&D to clinical validation and productization.
The company has established strong partnership networks and has the foundation in place for global expansion.
a.cure expands beyond heart failure to kidney failure, COPD, and other conditions, positioning as a leader in voice biomarkers.
Promotional video
Exhibit Item
[Heart to Voice] AI-powered voice biomarker solution for early detection and severity assessment of heart failure
Exhibit Item Images
-
Product Name : Heart to Voice“Heart to Voice” An AI-powered voice biomarker solution for early detection and severity assessment of heart failure. The platform delivers non-invasive, highly accurate results (>95%) in under 1 minute, enabling scalable deployment across hospitals, insurers, and consumer health markets.
Exhibit Description
“Heart to Voice” is an AI model integrating voice and clinical indicators, enabling prediction of clinical markers from voice alone to assess presence and severity of heart failure. It focuses on early detection and proactive management, applied to rapid testing in hospitals and long-term care facilities, as well as monitoring services for seniors.
Co-Exhibitor or
Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.